The Role of Sarcopenia in Heart Failure with Depression

Area of Science:

• Cardiology
• Psychiatry
• Geriatrics

Background:

• Heart failure (HF) and depression are prevalent conditions with a bidirectional association.
• Depression is a significant risk factor for heart disease, increasing HF incidence.
• Comorbid depression in HF patients leads to higher hospitalization, mortality, and reduced physical function.

Purpose of the Study:

• To explore the intricate linkage between heart failure, depression, and sarcopenia.
• To elucidate the shared pathophysiological mechanisms underlying these interconnected disorders.
• To summarize current and potential treatment strategies for comorbid HF, depression, and sarcopenia.

Main Methods:

• Literature review focusing on the association between HF, depression, and sarcopenia.
• Analysis of pathophysiological pathways common to HF, depression, and sarcopenia.
• Synthesis of evidence regarding therapeutic interventions.

Main Results:

• Shared mechanisms include malnutrition, physical inactivity, endocrine disorders, and chronic inflammation.
• Sarcopenia, characterized by muscle mass loss and weakness, exacerbates HF and depression symptoms.
• Enhanced muscle function is crucial for improving prognosis in patients with HF and depression.

Conclusions:

• HF, depression, and sarcopenia represent a complex triad with overlapping pathogenesis.
• Targeting sarcopenia alongside traditional HF and depression treatments is a promising therapeutic approach.
• Further research is warranted to optimize integrated management strategies for these comorbid conditions.